Home > Publications database > Synthesis and Binding Mode Predictions of Novel Siglec-7 Ligands. > print |
001 | 284421 | ||
005 | 20240918103855.0 | ||
024 | 7 | _ | |a 10.1021/acs.jmedchem.3c01349 |2 doi |
024 | 7 | _ | |a pmid:37793071 |2 pmid |
024 | 7 | _ | |a 0095-9065 |2 ISSN |
024 | 7 | _ | |a 0022-2623 |2 ISSN |
024 | 7 | _ | |a 1520-4804 |2 ISSN |
024 | 7 | _ | |a 1943-2992 |2 ISSN |
037 | _ | _ | |a DKFZ-2023-02010 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Frank, Martin |0 0000-0002-1006-6746 |b 0 |e First author |
245 | _ | _ | |a Synthesis and Binding Mode Predictions of Novel Siglec-7 Ligands. |
260 | _ | _ | |a Washington, DC |c 2023 |b ACS |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1726648715_16238 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:W160# / 2023 Oct 26;66(20):14315-14334 |
520 | _ | _ | |a Siglec-7 regulates immune cell activity and is a promising target for immunomodulation. Here, we report the discovery of novel sialic acid derivatives binding to Siglec-7. Synthesis and affinity measurements are complemented by high-quality models of sialoside-Siglec-7 complexes based on molecular dynamics (MD) simulations on the microsecond time scale. We provide details for the predicted binding modes for the new ligands, e.g., that an extension of the carbon backbone leads to a different molecular interaction pattern with the receptor and the nearby water structure than found for known Siglec-7 ligands. Further on, we uncover some shortcomings of the GLYCAM06 and GAFF2 force fields when used for the simulation of sialoside-based glycomimetics. Our results open new opportunities for the rational design of Siglec-7 inhibitors. In addition, we provide strategies on how to use and visualize MD simulations to describe and investigate sialoside-Siglec complexes in general. |
536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Kuhfeldt, Elena |b 1 |
700 | 1 | _ | |a Cramer, Jonathan |0 0000-0001-9869-5645 |b 2 |
700 | 1 | _ | |a Watzl, Carsten |b 3 |
700 | 1 | _ | |a Prescher, Horst |0 0000-0002-4882-2252 |b 4 |
773 | _ | _ | |a 10.1021/acs.jmedchem.3c01349 |g p. acs.jmedchem.3c01349 |0 PERI:(DE-600)1491411-6 |n 20 |p 14315-14334 |t Journal of medicinal chemistry |v 66 |y 2023 |x 0095-9065 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:284421 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 0000-0002-1006-6746 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
914 | 1 | _ | |y 2023 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-09-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1200 |2 StatID |b Chemical Reactions |d 2023-09-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1210 |2 StatID |b Index Chemicus |d 2023-09-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-09-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-09-04 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-21 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-21 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J MED CHEM : 2022 |d 2023-10-21 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-21 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-21 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J MED CHEM : 2022 |d 2023-10-21 |
920 | 1 | _ | |0 I:(DE-He78)W160-20160331 |k W160 |l Molekulare Strukturanalyse |x 0 |
920 | 0 | _ | |0 I:(DE-He78)W160-20160331 |k W160 |l Molekulare Strukturanalyse |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)W160-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|